Biocon Biologics
Arshad Jamil is a Senior IP Lawyer and Strategist with extensive experience in handling Biosimilars litigations, maintaining IP portfolios, and managing IP budgets. Arshad has held key positions at companies such as Biocon Biologics and SUN PHARMA, where Arshad was responsible for handling litigations and settlements. With a background in engineering, law, and business administration, Arshad brings a diverse skill set to their role. Arshad's early career as an Advocate in the High Court of Uttarakhand and District Court provided him with a solid foundation in legal practice. Additionally, their work as a Project Officer at the National Institute of Hydrology showcases their expertise in flood forecasting systems.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics